Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 14:47 ET | Source: Allsup

Allsup Highlights How Brain Injuries Can Qualify Workers For SSDI Benefits

Belleville, Illinois, March 24, 2026 (GLOBE NEWSWIRE) -- During Brain Injury Awareness Month, Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation is...
December 23, 2025 19:45 ET | Source: Agios Pharmaceuticals, Inc.

U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia

Agios today announced that the U.S. FDA has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, for thalassemia
December 17, 2025 07:00 ET | Source: CMR Surgical

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system

16 December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial...
December 17, 2025 02:00 ET | Source: CMR Surgical

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system

16 December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial...
December 16, 2025 06:00 ET | Source: McEwen Inc.

McEwen Secures Key Permit for El Gallo Mine; Mill Construction to Begin Mid-2026 - First Gold Pour Mid-2027

TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) is pleased to announce that the extension of its Environmental Impact Assessment (Manifestación de...
December 10, 2025 05:35 ET | Source: Boehringer Ingelheim Limited

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years.PPF is a rare lung condition, more life-threatening than many...
November 14, 2025 10:45 ET | Source: Green Rain Energy Holdings

Green Rain Energy Holdings Inc. (OTCID: GREH) Issues Updated Special Dividend Announcement

BEVERLY HILLS, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Green Rain Energy Holdings Inc. (OTC: GREH) announces updated details regarding its previously disclosed special stock dividend regarding the...
September 03, 2025 08:19 ET | Source: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals...
August 04, 2025 16:01 ET | Source: Agios Pharmaceuticals, Inc.

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios Pharmaceuticals today announced that the Saudi Food and Drug Authority has approved PYRUKYND® for the treatment of adult patients with thalassemia
July 25, 2025 07:00 ET | Source: Sobi, Inc.

Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in...